Table 3.
Risk factor | Clinical trial | Histology | TMN stage | Patients | Comparison | Risk region |
UIP | Watanabe et al[113] | NSCLC | Surgically | 526 | Lobe distribution Location | Lower lobe region Subpleural location (peripheral type A) |
Air flow limitation | Shin et al[119] | ADC SQC SCLC Others | NM | 754 | Location Central vs. Peripheral | Peripheral ADC and No emphysema SQC and Emphysema |
IPF | Liu et al[114] | ADC SQC SCLC | NM | 46 | Lobe distribution Location | Peripheral and upper lobes |
IPF | Lin et al[89] | ADC SQC SCLC LAC AQC | Stage I–IV | 6384 | Lobe distribution Location | Peripheral and lower part |
IPF | Nezka et al[120] | ADC SQC AQC | IA–IIIA | 641 | Lobe distribution | Lower Lung lobes |
IIPs | Fukui et al[117] | SQC Non-SQC | Stage I–III | 1972 | Lower lobectomy Upper lobectomy | Lower lobectomy |
ADC: Adenocarcinoma; AQC: Adenosauamous cell carcinoma; IIPs: Idiopathic interstitial pneumonias; LAC: Large-cell carcinoma; NM: Not mentioned; NSCLC: Non-small cell lung cancer; SCLC: Small-cell lung cancer; SQC: Squamous cell carcinoma; UIP: Usual interstitial pneumonia.